Literature DB >> 28475517

Hailey-Hailey Disease With Coexistent Herpes Virus Infection: Insights Into the Diagnostic Conundrum of Herpetic/Pseudoherpetic Features in Cutaneous Acantholytic Disorders.

Claire S Leitch1, Anusha P Panthagani2, Michael J Tidman1, Asok Biswas3.   

Abstract

The specific histopathologic diagnosis of a primary acantholytic disorder takes into account the distribution and extent of acantholysis, presence or absence of dyskeratosis, nature of the dermal inflammatory cell infiltrate, and immunofluorescence findings. Herpes virus infection is a common cause of secondary acantholysis where distinctive viral cytopathic changes aid in making it a clear-cut diagnosis in majority of cases. We present a case of coexistence of Hailey-Hailey disease and herpes simplex virus infection to compare and contrast their histopathologic features. This is imperative because acantholytic cells from primary acantholytic disorders may occasionally show cytological features traditionally associated with herpes virus infection (pseudoherpetic changes). The objective of this article is to create a greater awareness of pseudoherpetic changes and also to explore the clinical significance of coexistence of a primary acantholytic disorder and herpes virus infection, as in this case.

Entities:  

Mesh:

Year:  2018        PMID: 28475517     DOI: 10.1097/DAD.0000000000000902

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Hailey-Hailey Disease with Superimposed Eczema Herpeticum Caused by Herpes Simplex Virus Type 2 Infection in a Burn Unit: A Case Report and Literature Review.

Authors:  An Guo Michael Chin; Mohammed Asif; Charles Hultman; Julie Caffrey
Journal:  Cureus       Date:  2019-10-14

2.  Comment on 'Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital'. Pseudoherpetic Grover disease seems to occur in patients with COVID-19 infection.

Authors:  M Llamas-Velasco; P Chicharro; P Rodríguez-Jiménez; L Martos-Cabrera; D De Argila; M Fernández-Figueras; J Fraga
Journal:  Clin Exp Dermatol       Date:  2020-07-13       Impact factor: 4.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.